#F007#
Fungicida
INPYRFLUXAM
Fungicide
GROUP
FRAC 7
GROUP NAME
SDHI - Succinate dehydrogenase inhibitors
MoA (Mode of Action)
Inhibition of mitochondrial respiration (complex II)
RESISTANCE LEVEL
Medium-high
CLASSIFICATION
Systémique et translaminaire
TYPE
Specific site
ACTIVITY
Primarily preventative, with a slight initial curative action.
Description
A systemic fungicide belonging to the SDHI carboxamide group, with high preventative activity and persistence against various fungal diseases. It acts by inhibiting the succinate dehydrogenase enzyme in the mitochondrial respiration of the fungus, blocking energy production and halting pathogen growth. It exhibits translaminar action, good mobility, and a broad spectrum of control.
Application Conditions
It should be applied preventively or in the early stages of infection by foliar spraying, ensuring uniform coverage of the crop. Alternating with fungicides of a different mode of action is recommended, and usage limitations should be respected to minimize the risk of resistance development.
Compatibility in Treatment Programs
Compatible with multi-site fungicides and IPM programs; alternation with different FRACs is recommended.
Cross-Resistance
Yes, partial or total cross-resistance with other SDHI fungicides of the FRAC group 7
Maximum Number of Applications
Maximum 1-2 consecutive applications depending on the crop and anti-resistance strategy
Recommendations for Use
Recommended in mixture or alternation with multi-site fungicides to reduce selection pressure
Compatibility with Beneficial Organisms
Generally yes when used according to labeling, although there may be limited impact on non-target organisms.
Technical Notes
Inpirfluxam stands out for its high preventative efficacy and persistence against important foliar diseases. Due to the risk of resistance development characteristic of the SDHI group, it is essential to integrate it into resistance management programs with alternating modes of action and limiting consecutive applications.
Products Based on:
INPYRFLUXAM
Related Treatments
Explore more tools
Services
Contact
Legal
©2023 por ZeriMar Laboratoire. Todos los derechos reservados.